Your browser doesn't support javascript.
loading
Mortality Risks Associated with Depression in Men with Prostate Cancer.
Crump, Casey; Stattin, Pär; Brooks, James D; Sundquist, Jan; Sieh, Weiva; Sundquist, Kristina.
Afiliação
  • Crump C; Department of Family and Community Medicine, The University of Texas Health Science Center, Houston, TX, USA; Department of Epidemiology, The University of Texas Health Science Center, Houston, TX, USA. Electronic address: casey.crump@uth.tmc.edu.
  • Stattin P; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Brooks JD; Department of Urology, Stanford University School of Medicine, Stanford, CA, USA.
  • Sundquist J; Center for Primary Health Care Research, Lund University, Malmö, Sweden.
  • Sieh W; Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
  • Sundquist K; Center for Primary Health Care Research, Lund University, Malmö, Sweden.
Eur Urol Oncol ; 2024 Apr 03.
Article em En | MEDLINE | ID: mdl-38575410
ABSTRACT

BACKGROUND:

Men diagnosed with prostate cancer (PC) have an increased risk of depression; however, it is unclear to what extent depression affects long-term survival. A better understanding of such effects is needed to improve long-term care and outcomes for men with PC.

OBJECTIVE:

To determine the associations between major depression and mortality in a national cohort of men with PC. DESIGN, SETTING, AND

PARTICIPANTS:

A national cohort study was conducted of all 180 189 men diagnosed with PC in Sweden during 1998-2017. Subsequent diagnoses of major depression were ascertained from nationwide outpatient and inpatient records through 2018. OUTCOME MEASUREMENTS AND STATISTICAL

ANALYSIS:

Deaths were identified from nationwide records through 2018. Cox regression was used to compute hazard ratios (HRs) for all-cause mortality associated with major depression, adjusting for sociodemographic factors and comorbidities. Subanalyses assessed differences by PC treatment during 2005-2017. PC-specific mortality was examined using competing risks models. RESULTS AND

LIMITATIONS:

In 1.3 million person-years of follow-up, 16 134 (9%) men with PC were diagnosed with major depression and 65 643 (36%) men died. After adjusting for sociodemographic factors and comorbidities, major depression was associated with significantly higher all-cause mortality in men with high-risk PC (HR, 1.50; 95% confidence interval [CI], 1.44-1.55) or low- or intermediate-risk PC (1.64; 1.56-1.71). These risks were elevated regardless of PC treatment or age at PC diagnosis, except for youngest men (<55 yr) in whom the risks were nonsignificant. Major depression was also associated with increased PC-specific mortality in men with either high-risk PC (HR, 1.35; 95% CI, 1.28-1.43) or low- or intermediate-risk PC (1.42; 1.27-1.59). This study was limited to Sweden and will need replication in other countries when feasible.

CONCLUSIONS:

In this national cohort of men with PC, major depression was associated with ∼50% higher all-cause mortality. Men with PC need timely detection and treatment of depression to support their long-term outcomes and survival. PATIENT

SUMMARY:

In this report, we examined the effects of depression on survival in men with prostate cancer. We found that among all men with prostate cancer, those who developed depression had a 50% higher risk of dying than those without depression. Men with prostate cancer need close monitoring for the detection and treatment of depression to improve their long-term health outcomes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Mortalidade / Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Idioma: En Revista: Eur Urol Oncol Ano de publicação: 2024 Tipo de documento: Article